VirologyNews.net

Virology Xagena

Search results for "AIDS"

The final statement from the 1st European Consensus Conference on the Treatment of Chronic Hepatitis B and C in HIV Co-infected Patients, includes a definitive recommendation that HIV patients co-infe ...


FDA ( Food and Drug Administration ) has approved Pegasys ( Peginterferon alfa-2a ) and Copegus ( Ribavirin ) for the treatment of chronic hepatitis C in patients co-infected with hepatitis C and HIV. ...


In the fall of 2004, the NIH ( National Institute of Health ) requested that the Institute of Medicine ( IOM ) of the National Academies of Sciences review the HIVNET 012 perinatal HIV prevention tria ...


People with more copies of a gene that helps to fight HIV are less likely to become infected with the virus or to develop AIDS than those of the same geographical ancestry, such as European Americans, ...


Roche has obtained the European marketing approval for new 500 mg formulation of Invirase ( Saquinavir ), an protease inhibitor used in the treatment of HIV infection. The new 500 mg tablet will simp ...


Researchers at the University of Michigan discovered a receptor that appears to function as one "lock" that herpes simplex virus ( HSV ) opens to allow it to enter human cells. They've also found the ...


Researchers have identified the first reported case in Asia of primate-to-human transmission of simian foamy virus ( SFV ), a retrovirus found in macaques and other primates that so far has not been s ...


Researchers at Temple University School of Medicine discovered that a novel protein, p27SJ, extracted from a callus culture of the St. John’s wort plant ( Hypericum perforatum ) suppresses HIV-1 expr ...


A trial, published in The Lancet, found that Zinc supplements are a safe, simple, and cost-effective method of reducing illness in children infected with HIV. Previous studies have shown that Zinc ...


Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. For other medications, resistance occurs only when patients take most ...


The enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollment was sto ...


Researchers at Johns Hopkins and other institutions has found that a once-daily combination of three antiretroviral drugs works better as an initial treatment for HIV infection than another three-drug ...


Researchers at Johns Hopkins say an infected person's HIV subtype is a better predictor than viral load for determining rapid death from AIDS. Traditional testing standards help monitor the progress ...


Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma lipids in patients with HIV-1 on HAART ( Highly Active AntiR ...


Researchers at the University of Illinois at Chicago and two other institutions have unraveled the structure of an important new drug target from the virus that causes SARS, severe acute respiratory s ...